Pyxis Oncology (PYXS) Stock Chart & Stock Price History $1.38 +0.02 (+1.10%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Pyxis Oncology Stock Price Performance The Pyxis Oncology (PYXS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 62.33%, with a year-to-date return of -11.86%. In the past month, the stock has increased 12.24%, reflecting recent market activity. As of the latest close, Pyxis Oncology traded at $1.36 with a market cap of $84.34 million and volume of 139,052 shares. Receive PYXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.61%1 Month Performance+12.24%3 Month Performance+14.58%Year-To-Date Performance-11.86%1 Year Performance-62.33% PYXS Stock Chart for Thursday, August, 28, 2025 PYXS Chart by TradingView Pyxis Oncology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/27/2025$1.37$1.36-0.73%$1.38$1.32139,052 shs$84.34 million08/26/2025$1.39$1.37-1.44%$1.40$1.33223,141 shs$84.97 million08/25/2025$1.34$1.39+3.73%$1.40$1.31592,194 shs$86.21 million08/22/2025$1.32$1.34+1.52%$1.43$1.281.33 million shs$83.11 million08/21/2025$1.16$1.32+13.79%$1.35$1.142.10 million shs$81.87 million08/20/2025$1.20$1.16-3.33%$1.22$1.15224,161 shs$71.86 million08/19/2025$1.24$1.20-3.23%$1.24$1.17403,333 shs$74.34 million08/18/2025$1.23$1.24+0.81%$1.25$1.20266,431 shs$76.82 million08/15/2025$1.13$1.23+8.85%$1.25$1.13673,225 shs$76.20 million08/14/2025$1.07$1.13+5.61%$1.13$1.06332,829 shs$70.00 million Get the Latest News and Ratings for PYXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. 08/13/2025$1.04$1.07+2.88%$1.10$1.02311,888 shs$66.29 million08/12/2025$1.04$1.04$1.06$1.00198,219 shs$64.43 million08/11/2025$1.06$1.04-1.89%$1.07$0.97770,810 shs$64.43 million08/08/2025$1.07$1.06-0.93%$1.07$1.00379,719 shs$65.67 million08/07/2025$1.05$1.07+1.90%$1.09$1.03142,929 shs$66.29 million08/06/2025$1.08$1.05-2.78%$1.10$1.03284,178 shs$65.05 million08/05/2025$1.10$1.08-1.82%$1.14$1.08183,872 shs$66.90 million08/04/2025$1.10$1.10$1.14$1.09240,357 shs$68.15 million08/01/2025$1.12$1.10-1.79%$1.13$1.09164,183 shs$68.15 million07/31/2025$1.15$1.12-2.61%$1.17$1.10199,994 shs$69.38 million07/30/2025$1.14$1.15+0.88%$1.20$1.13146,803 shs$71.24 million07/29/2025$1.23$1.14-6.94%$1.24$1.14300,754 shs$70.62 million07/28/2025$1.25$1.23-2.00%$1.28$1.22200,408 shs$75.89 million Related Companies FDMT Stock Price Chart AMRN Stock Price Chart ZYBT Stock Price Chart CADL Stock Price Chart CAPR Stock Price Chart LRMR Stock Price Chart DMAC Stock Price Chart FHTX Stock Price Chart ALT Stock Price Chart DRUG Stock Price Chart Receive PYXS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pyxis Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PYXS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pyxis Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pyxis Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access